Objective: We aimed to evaluate the viral load and integration status of human papillomavirus 58 in women with different grades of cervical lesions to determine whether viral load and integration status are related to malignant transformation in HPV58-infected women. Methods: A total of 212 cervical specimens were collected from women in Northeast China who had undergone human papillomavirus genotyping and were HPV58-positive. The HPV58 viral load was determined using real-time polymerase chain reaction, and the integration status was discriminated using the ratio of HPV58 E2 gene copy number to E6 gene copy number. Results: The median HPV58 viral load in women with normal cervix or cervicitis, low-grade squamous cell intraepithelial lesion, high-grade squamous cell intraepithelial lesion and cervical cancer was 352.12, 864.21, 1199.75 and 693.04 copies/genome, respectively. High significance was obtained when comparing the viral load of infected women presenting normal/cervicitis with that of the women either with precancerous cervical lesions or cervical cancer (P < 0.05). The HPV58 genome was in the episomal form in 35 samples (16.5%), mixed episomal and integrated forms in 165 (77.8%) samples, and completely integrated into the host genome in 12 (5.7%) samples. The HPV58 E2/E6 copy number ratio in the cervical cancer group was significantly lower than that in the other groups (P < 0.01). Conclusions: The HPV58 viral load in patients with precancerous cervical lesions or cervical cancer increases significantly with disease progression. The HPV58 E2/E6 copy number ratio in patients with cervical cancer is lower than that for less severe cervical lesions, suggesting a high degree of viral integration may be a considerable risk factor for cervical cancer.
Introduction
Cervical cancer (CC) is the second most frequent cancer in women worldwide (1) . High-risk human papillomaviruses (HR HPVs) are risk factors for the development of CC and are associated with 99% of all cervical carcinomas (2) . However, HPV infection is mostly a transient phenomenon, resulting in no cervical lesions or in lowgrade lesions that often regress spontaneously (3, 4) . Cervical carcinomas only arise in the presence of long-term, persistent infections with HR HPVs. New predictive markers for clinical outcomes in women with HR HPVs infections, such as viral load and integration status, need to be evaluated.
Two types of HPV, HPV16 and HPV18, account for approximately two-thirds of malignant lesions worldwide (1) . The available prophylactic bivalent and quadrivalent vaccines are expected to reduce CC in 70% of women. Until now, most studies examining viral load and integration status have focused on HPV16 or HPV18 (5-7), rather than other HR HPV types (8, 9) . However, HPV58 is a major cause of cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma in Asia, especially in China (10) . In addition, the commercially available HPV vaccines do not target HPV58. In our previous study, although we found high ratios of HPV58 E6, E7, L1 and long control region (LCR) variants in the studied strains, no variant was significantly associated with the severity of the cervical lesions in the infected women (11) . Therefore, it is necessary to find new diagnostic biomarkers for prevention of CC caused by HPV58 infection.
Among women with HR HPV infections, cytological abnormality is more commonly found in those with higher viral load (12, 13) . However, some studies have reported controversial results, failing to reveal a consistent association between the HPV viral load and the risk of acquiring a cytological abnormality of the cervix (14, 15) . Previous studies have reported an association between HPV integration and increasing severity of cervical lesions (13, 16) . Thus, the HPV sequence is found in episomal form in most patients with normal and low-grade precancerous lesions (17) , whereas viral DNA is integrated into the host genome, either as single or multi-copy DNA, in most cases of cervical carcinomas or high-grade precancerous lesions (18, 19) . The integration of viral DNA into the host cellular genome usually disrupts the E2 gene, causing a lack of the E2 repressor protein (20) , which leads to subsequent overexpression of the viral oncogenes E6 and E7 (21) . The integration status of HR HPVs in women with cervical lesions can be inferred by the E2/E6 ratio and used to evaluate the severity of the cervical lesion. Current data on HPV integration are mainly from studies examining HPV16 and HPV18. These studies suggest that the integration of HR HPV in women with cervical lesions is type-dependent (13, 22, 23) . However, Chinese and other Asian women have a higher prevalence of HPV58 compared with other women worldwide (10) . Therefore, the aim of this study was to detect the viral load and chromosomal integration status of HPV58 in Chinese women having various grades of cervical lesions. The relationships among viral load, HPV58 integration status and severity of the cervical lesion in HPV58-infected women were analyzed.
Patients and methods

Study population and specimen collection
A total of 212 participants with a single infection of HPV58 were selected from women admitted to the Affiliated Shengjing Hospital of China Medical University from September 2011 to October 2015. Residual cervical swabs were collected after routine HPV detection and typing were conducted using an HPV GenoArray test kit (HybriBio Ltd, Hong Kong) as previously described (10) . In brief, cellular DNA was extracted according to the manufacturer's instructions. The quality of the extracted DNA was ascertained by polymerase chain reaction (PCR) using β-globin primers (268 bp product). HPV genotyping was performed on a flow-through hybridization principle and is able to classify 21 HPV genotypes, including 13 high-risk types (HPV16, 18, 31, 33, 35, 39, 45 , 51, 52, 56, 58, 59 and 68), 5 low-risk types (HPV6, 11, 42, 43 and 44) and 3 types common in China (HPV53, 66 and 81). Clinical cytological and histologic diagnoses were recorded and classified as normal, low-grade squamous cell intraepithelial lesion (LSIL), high-grade squamous cell intraepithelial lesion (HSIL) and CC. The study was approved by the Shengjing Hospital Ethics Committee.
DNA extraction
The collected cervical specimens were kept at temperatures between 2 and 8°C until DNA extraction. The specimens were dissolved in normal saline using the oscillation for 1 min. After being centrifuged for 5 min (4°C, 12 000 × g/min), the sediment was resuspended in 50 µL of DNA extraction solution (Guangzhou Da'an Diagnostic Co. Ltd, China). After being heated at 100°C for 10 min, the sample was centrifuged for 5 min (4°C, 12 000 × g/min). The extracted DNA was stored at −80°C for quantitative (q) PCR analysis.
Plasmid construction and quantification of HPV58 E2 and E6 standard fragments
The primer sequences used for each target are E2-F 5′-ggtagtcgggtaattgtatgtcc-3′ and E2-R 5′-cgtcgctttgtcccctgtg-3′, and E6-F 5′-atgttccaggacgcagag-3′ and E6-R 5′-gcattcaacgcat ttcaa-3′, respectively. The amplified products of E2 and E6 were ligated to separate pCR 2.1 vectors (Life Technologies, USA). Then, the recombinant vectors were transformed in chemically competent Escherichia coli (E. coli) TOP10 cells. The HPV E2 and E6 fragments inserted into selected pE2 and pE6 plasmids were confirmed using PCR amplification and sequencing methods. The E. coli TOP10 cells containing pE2 and pE6 were cultured in standard LB medium for~14 h. The pE2 and pE6 plasmids were then purified using a modified alkaline lysis procedure conducted with a QIAGEN Plasmid Mini Kit. The concentrations of the pE2 and pE6 plasmids were determined by spectrometry at a wavelength of 260 nm and adjusted to 1 × 10 10 copies/μl each.
Real-time SYBR green PCR assays
On the basis of the assumption that integration of HPV58 results in the disruption of the E2 gene, viral integration was inferred by comparing the levels of E2 and E6 genes as measured by real-time PCR.
To account for the possibility that disruption might involve only part of the E2 gene, real-time PCR assays targeting the commonly disrupted regions of the E2 gene were performed on all samples (24) . Real-time PCR was performed using Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) with an ABI Prism 7300 Sequence Detection System (Applied Biosystems). The PCR amplification mixture included 5 μl of genomic DNA, 25 μl of Power SYBR Green PCR Master Mix and 0.2 mM primers for E2 or E6 genes. PCR was performed under the following cycling conditions: 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. The amplification products were identified using melting curves with a thermal profile. Detections of E2 and E6 were conducted in triplicate for each sample. As an internal control, the β-actin gene copy number in all samples was detected as previously described (25) . A commercial β-actin DNA template (TaqMan DNA template reagent; Applied Biosystems) was used to generate the standard curve. The reaction mixture without any sample present was used as the negative control in each run. One positive control sample, which had been quantified previously, was also included in each run. The copy numbers in samples were calculated using the second derivative maximum method with LightCycler 480 software version 1.5.0. To quantify HPV58 E2 and E6 gene copy numbers, standard curves were generated using 10 copies of pE2 and pE6 plasmids as described above. Each pE2 or pE6 plasmid concentration was amplified using real-time PCR three times. The linear relationship between the log copy number of the gene and the threshold cycle (C t ) value was evaluated. Based on the standard sample data obtained from the PCR system, the linear regression formulas derived for E2 and E6 were y = −3.4418x + 40.975 and y = −3.503x + 41.103, respectively. To determine the E2 and E6 gene copy numbers, the C t value for each PCR reaction was regressed using the linear regression formula for E2 and E6, respectively. The number of single-copy β-actin genes was used to correct the HPV copy number for the number of cells contained in the cervical swab material. The HPV58 viral load was derived based on the E6 copy number, which was normalized to the level of β-actin and presented as copies/genome equivalent. All qPCR reactions were run in triplicate. The mean values were used for statistical analysis.
Determination of cutoff values for discriminating viral integration status in the amplification system
Because the HPV integration process often disrupts the E2 gene, the ratio of the E2 and E6 gene numbers in a given sample represents the viral integration status. To verify the accuracy of the amplification system for detecting HPV58 E2 and E6 copy numbers and determine the cutoff values for discriminating viral integration states, the E2 and E6 loads in mixed DNA solutions containing equivalent HPV58 E2 and E6 plasmids (ranging from 10 7 to 10 copies) were detected in three independent repetitions. The cutoff value for discriminating the viral integration status was calculated as the average ratio (mean ± SE) of the E2 and E6 loads contained in the amplification system. The numbers of E2 and E6 copies in each sample were determined quantitatively in triplicate. The viral integration status in an individual sample was discriminated by comparing the ratio of the E2 and E6 gene copy numbers.
Statistical analysis
Means, medians, ranges and interquartile ranges were used as descriptive statistics. The Mann-Whitney U-test or Kruskal-Wallis test was used to compare pairs of cytological groups. Pearson's Chisquared test was used to relate integration status to the cytological categories. The values for the E2/E6 ratio of the different cytological categories were compared using one-way analysis of variance. P values <0.05 were considered significant. All statistical analyses were performed with SPSS version 16.0.
Results
Characteristics of the participants
Among the cervical samples obtained from the 212 HPV58-infected patients, 64 were found to be normal or showing cervicitis, 59 were classified as LSIL, 60 as HSIL and 29 as CC. The age of the women ranged from 22 to 67 years, with a mean age of 41.7 ± 6.8 years. The mean age of the patients in the normal and cervicitis group was 39.6 years, and the mean ages of the patients in the LSILs, HSILs and CC groups were 41.1, 42.9 and 49.3 years (range, 35-62 years), respectively. The mean age of the patients with CC was significantly greater than that of the other three groups (P < 0.05).
HPV58 viral load and relationship to histomorphological findings of infected women
All cervical scrapes were obtained from HPV58-positive women who participated in colposcopic examinations and biopsies. The viral loads in the cervical swabs were normalized to the level of β-actin (copies/ genome equivalent) and described using means, medians and interquartile ranges (Fig. 1) . The viral load median in the normal and cervicitis group was 352.12 copies/genome, 864.21 copies/genome in Figure 1 . The relationship between HPV58 viral load and histopathology of cervical samples. For each box, the horizontal line indicates the median value of the viral load, the vertical height of the box indicates the interquartile range and the whiskers above and below the box indicate the upper and lower range of the data. NM, normal; LSIL, low-grade squamous cell intraepithelial lesion; HSIL, high-grade squamous cell intraepithelial lesion; CC, cervical cancer.
the LSIL group, 1199.75 copies/genome in the HSIL group and 693.04 copies/genome in the CC group. High significance was obtained when comparing the viral load of infected women presenting normal/cervicitis with women either with precancerous cervical lesions or CC (P < 0.05). Except for the CC group, the viral load increased with the severity of the cervical lesion.
Integration status of HPV58 and relationship to histomorphological findings of infected women
The ratio of the E2-E6 gene copy numbers in each sample was calculated and the infection status was evaluated based on the cutoff value. As a proxy for integration status, the cutoff value of E2/E6 ratio for discriminating HPV58 integration states in the amplification system was 0.802 ± 0.036. Ratio of E2 and E6 numbers <0.033 indicates that the viral E2 gene is completely disrupted (Integration form), >0.766 indicates that the viral DNA is in an episomal form and value between 0.036 and 0.766 indicates that the E2 gene is partially disrupted and considered as mixed episomal and integrated form. The HPV58 E2/E6 ratio in the samples ranged from 0.05 ± 0.02 to 1.08 ± 0.03 (median, 0.88 ± 0.03), indicating that the mixed form was the most common in the 212 HPV58-positive samples (77.8%, 165/212). Thirty-five samples (16.5%, 35/212) did not show decreased E2 gene copy numbers, indicating the episomal form of the virus. Only 12 (5.7%, 12/212) samples collected from women with endometrioid adenocarcinomas had completely disrupted E2 genes, indicating full integration of the viral DNA into the host genome. The integration status among each group showed no statistical difference. The HPV58 E2/E6 ratios in the normal or cervicitis, LSIL and HSIL groups were similar, whereas that in the CC group (0.50 ± 0.31) was significantly lower than that in the other groups (P < 0.01; Fig. 2) . The relationship between integration status and lesion grade is presented in Table 1 .
Association between viral load and integration status of HPV58
The distribution of the viral load versus the various categories of integration status is shown in Table 2 . Means, medians, interquartile ranges and ranges of HPV58 viral loads were used to describe the viral loads. As stated above, 35 (16.5%) cervical samples showed episomal HPV DNA, 165 (77.8%) showed mixed episomal and integrated DNA and 12 (5.7%) showed completely integrated DNA. The median viral load in the mixed DNA group was lower than that in the episomal DNA group, although the difference between the two groups was not statistically significant according to the MannWhitney U-test result (P > 0.05).
Discussion
The distribution of HPV types is correlated with the geographic origins of the infected patients. In China and some other areas of Asia, Figure 2 . HPV58 E2/E6 copy number ratios in patients with various grades of cervical lesions. The HPV58 E2/E6 ratio in the CC group was compared with those in the normal or cervicitis, LSIL, and HSIL groups. *P < 0.01. NM, normal; LSIL, low-grade squamous cell intraepithelial lesion; HSIL, high-grade squamous cell intraepithelial lesion; CC, cervical cancer. HPV58 ranks as the second or third most commonly found HPV in cervical lesions of HPV-positive women (26, 27) .
This study investigated that the viral load and integration status of HPV58 and their relationships to histomorphological findings in women infected with this virus by using quantitative real-time PCR to evaluate the presence of HPV58 E6 and E2 genes. The viral load was normalized to the cell number in each sample through the additional measurement of the single-copy gene β-actin. This method is superior to the semi-quantitative measurement of viral load conducted using either relative light unit/cutoff values, in which the cell number of the analyzed sample is unknown and multiple infections may cause a viral load that is not attributable to a distinct HPV type, or using dot blot analysis with an estimated signal strength (28) .
A total of 212 samples singly infected with HPV58 were selected from patients with various cervical lesion grades, including 64 samples that were histomorphologically normal or showed evidence of cervicitis, 59 samples with LSIL, 60 with HSIL and 29 with CC. Among patients with one of these four categories of cervical lesions, those with CC were significantly older than those in the other three categories, which showed no significant age difference.
The association between viral load and severity of cervical lesion is under debate. Several studies have shown that higher viral loads of HPV16 and HPV18 are associated with high-grade cervical lesions (29, 30) . A high HPV16 viral load was reported to confer an increased risk of squamous cell carcinoma beginning 3 years before diagnosis (relative risk, 60; 95% confidence interval: 6-580) (31). However, some researchers have also suggested that there is no association between HPV16 viral load and disease progression (32, 33) . The results of our study showed that the HPV58 viral load in patients gradually increased with disease progression from normal or cervicitis to LSIL and HSIL. By contrast, the HPV58 viral load in patients with CC was lower than that in patients with LSIL or HSIL. However, these differences were not statistically significant. These data are not entirely consistent with the results obtained in a study conducted in Hong Kong that revealed that the median HPV58 viral load in only the CIN1/2 group was significantly higher than that in groups of patients with other cervical lesions (8) . However, the viral load of patients with normal cervices and those with invasive cervical cancer (ICC) was not significantly different (8) . Ho et al. (9) also showed no significant difference in HPV58 viral loads between CIN2/3 and ICC patients. A high viral load of other HR HPVs, including HPVs 16, 18 and 52, has also been considered a prognostic factor of cervical lesion (9, 34) . Based on our data, however, the HPV58 viral load is not a predictive biomarker for the severity of cervical lesion.
The integration of HPV DNA into host cellular chromatin is considered a major contributing factor to the malignant transformation of the genital tract. The integration of the HPV genome often disrupts the E2 viral gene, resulting in removal of E6/E7 viral oncogene inhibition and promotion of E6/E7 transformation progression (35, 36) . The present investigation was based on the assumption that episomal E2 and E6 gene forms have the same copy number and that disrupting the E2 gene during integration would decrease the detectable number of E2 copies. Determining the E2/E6 ratios then enabled us to assess the integration status of the viral genome. Our results indicated that 16.5% of the cervical samples had episomal HPV DNA, 77.8% showed mixed episomal and integrated DNA, and 5.7% had purely integrated DNA. Thus, most HPV58 strains showed mixed patterns of disruption, with even 80.0% of patients in the group with normal or inflamed cervices having mixed episomal and integrated HPV DNA. This is in line with a previous population-based study that reported that 61.3% (46/75) of the samples obtained in the Hong Kong area showed a mixture of integrated and episomal forms (8) . Our results showed that the pure episomal form was found in only 35 samples (16.5%), indicating that viral integration may occur during the early stages of infection. This HPV58 early-stage integration may differ from the HPV16 infection process, in which 72.2% of patients with CINI reportedly have the episomal form, 73.5% of patients with CINII/III have mixed DNA forms and 81.8% of patients with CC show only integrated virus (37) . Another recent study that also evaluated viral integration using the E2/E6 ratio method found that integrated HPV16 genomes in patients with anal carcinoma were detectable in few cases (7.4%), whereas mixed (70.4%) and episomal (22.2%) forms were more common (38) . Thus, HPV58 and HPV16 may have different integration processes during the course of infection and different effects on disease progression.
The level of HPV58 integration was not significantly different among the normal or cervicitis, LSIL and HSIL groups. Only HPV58-positive patients with CC displayed integrated or mixed forms, of which 12 patients had pure integrated forms. This finding of a low level of pure integration in the CC group is similar to that in a report from a study conducted in Taiwan (9) . In that study, the integrated form of HPV58 DNA was found in only 12.5% of the swabs obtained from patients with CC. However, another study reported a high proportion (66.7%, 6/9) of pure integrated HPV58 DNA in cervical squamous cell carcinoma samples obtained from patients in Shantou, a city in southern China (25) . Our CC group included 13 cases of cervical carcinoma in situ and 16 cases of invasive CC, but the ratio of E2/E6 (0.50 ± 0.31) in this CC group was markedly lower than that in the other groups. This result suggests that a high degree of viral integration may be a novel prognostic factor, predicting CC in HPV58-infected patients. Because all of the studies discussed above used the same method, real-time PCR, the different levels of integrated virus reported may be due to the different integration abilities of HPV58 variants across various populations. For example, Chan et al. (8) showed that some HPV58 mutants are more likely to exist in the body in the episomal form. The results of this study provide the novel finding that HPV58 infection and integration are associated with CC in women in Northeast China.
By sustaining high levels of the E6 and E7 oncogenes, viral load is also suggested to be a key player in lesion development (39) . During the HPV integration process, the E2 gene is disrupted or completely deleted. The E2 protein has an auxiliary role to initiate viral DNA replication by recruiting the E1 helicase to the replication origin (40, 41) . Moreover, the heterodimer E8 ∧ E2C, which is generated by alternative splicing of the E8 ORF and fusing to the C-terminus of E2, inhibits the level of replication of HPV16 and HPV31 (42, 43) . Thus, the integration process may have bidirectional regulation of HPV DNA replication due to different disruption positions. This study found that the HPV58 viral load in samples with mixed integrated and episomal forms was similar to that in samples with only the episomal form. This result is consistent with that from a previous report (8) demonstrating that the viral load in samples with various integration statuses was not different. Nevertheless, the study contains some limitation, our assay did not directly detect viral genome integration but detected E2:E6 ratio based on the assumption that E2 is preferentially disrupted upon integration. However, a recent report by Hu et al. (44) revealed that breakpoints could occur in any part of the viral genome. Furthermore, breakpoints were prone to occur in E1 instead of E2 and less prone to occur in the LCR. The data provide insights into HPV integration-driven cervical carcinogenesis.
In summary, we found that the viral load of HPV58 in precancerous cervical lesion increases significantly with disease progression and that a high level of HPV58 was integrated into the host genome, even in patients with normal cervices and LSIL. Completely integrated HPV58 DNA was found only in patients with CC. The E2/E6 copy number ratio in patients with CC was significantly lower than that in patients having less severe cervical lesions, suggesting that a high degree of viral integration may be a considerable prognostic factor, predicting CC in patients with HPV58 infection.
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